The Paul G. Allen Frontiers Group is a Seattle-based bioscience research initiative started in 2016 and funded with an initial investment of $100 million.[1] It is a division of the Allen Institute.[2] Its vision is to identify areas in bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.[3]
In 2021, the Allen Frontiers Group joined the Open Research Funders Group (ORFG).[4]
Allen Distinguished Investigators
The Distinguished Investigator program "awards grants of $1.5 million of three years in support of early-stage research in biology and medicine that would not otherwise be supported by traditional funding sources."[5]